Cargando…
Metabolic Effects of Oral Phenelzine Treatment on High-Sucrose-Drinking Mice
Phenelzine has been suggested to have an antiobesity effect by inhibiting de novo lipogenesis, which led us to investigate the metabolic effects of oral chronic phenelzine treatment in high-sucrose-drinking mice. Sucrose-drinking mice presented higher body weight gain and adiposity versus controls....
Autores principales: | Carpéné, Christian, Gómez-Zorita, Saioa, Chaplin, Alice, Mercader, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213466/ https://www.ncbi.nlm.nih.gov/pubmed/30257452 http://dx.doi.org/10.3390/ijms19102904 |
Ejemplares similares
-
Resveratrol, Metabolic Syndrome, and Gut Microbiota
por: Chaplin, Alice, et al.
Publicado: (2018) -
Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase Inhibitors
por: Carpéné, Christian, et al.
Publicado: (2019) -
Hyperglycemia and reduced adiposity of streptozotocin-induced diabetic mice are not alleviated by oral benzylamine supplementation
por: Carpéné, Christian, et al.
Publicado: (2022) -
Opipramol Inhibits Lipolysis in Human Adipocytes without Altering Glucose Uptake and Differently from Antipsychotic and Antidepressant Drugs with Adverse Effects on Body Weight Control
por: Carpéné, Christian, et al.
Publicado: (2020) -
Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine
por: Matveychuk, Dmitriy, et al.
Publicado: (2021)